Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Nuclear Medicine and Biology|August 4, 2009
Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEKGanesan Vaidyanathan, Emmanuelle Jestin, Tove Olafsen, et al.
Dalton Transactions (Cambridge, England : 2003)|April 5, 2012
Structurally modified 1,10-phenanthroline based fluorophores for specific sensing of Ni2+ and Cu2+ ionsSelvam Sangeetha, Gopal Sathyaraj, Duraisamy Muthamilselvan, et al.
Nuclear Medicine and Biology|June 19, 2021
Labeling single domain antibody fragments with <sup>18</sup>F using a novel residualizing prosthetic agent - N-succinimidyl 3-(1-(2-(2-(2-(2-[<sup>18</sup>F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoateZhengyuan Zhou, Darryl McDougald, Rebecca Meshaw, et al.
Nuclear Medicine and Biology|May 10, 2015
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBGGanesan Vaidyanathan, Darryl McDougald, Eftychia Koumarianou, et al.
Nuclear Medicine Communications|August 21, 2004
Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cellsGanesan Vaidyanathan, Donna J Affleck, Kevin L Alston, et al.
Nuclear Medicine and Biology|February 7, 2006
Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearanceSriram Shankar, Ganesan Vaidyanathan, Chien-Tsun Kuan, et al.
Nuclear Medicine and Biology|May 20, 2025
Enhancing the therapeutic index of [<sup>211</sup>At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glandsTruc T Huynh, Yutian Feng, Rebecca L Banks, et al.
Nuclear Medicine and Biology|September 28, 2010
Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligandsMarc Hens, Ganesan Vaidyanathan, Xiao-Guang Zhao, et al.
Nuclear Medicine and Biology|May 26, 2020
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agentYutian Feng, Zhengyuan Zhou, Darryl McDougald, et al.
Current Radiopharmaceuticals|January 19, 2011
[Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of MedulloblastomaGanesan Vaidyanathan, Donna J Affleck, Xiao-Guang Zhao, et al.
Pageof 9